Login
Toggle navigation
Videos
Categories
Trending
Stephen Spencer, Managing Director at Houlihan Lokey, shares insights alongside the CEO of Capital Power on industry developments.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Scott Beiser is a Co-Chairman of Houlihan Lokey
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Tesla's Hydrogen-Powered Revolution|Elon Musk,CEO,Tesla
00:00:00
Luke J. Burchill, M.B.B.S., Ph.D. Cardiologist, Mayo Clinic
00:10:00
Shaping the Future of the Collision Repair Industry: Insights from Jason Moseley of IBIS Worldwide and Michel Malik of BodyShop News International | Jason Moseley - CEO, IBIS Worldwide | Michel Malik - CEO, BodyShop News International
00:10:00
Rolv Erik Ryssdal, CEO of Schibsted Norway, discusses industry insights during World Newspaper Week in Vienna, Austria.
00:10:00
Finding the Right Financial Planner After a Life-Changing Event
00:10:00
Forecasting Oil Prices: Elliot Shue’s Six Vital Indicators
00:10:00
#CEOTalks featuring Romina Parquet, CEO of CIMC Wetrans in Argentina, discuss industry insights and developments with MetroGAS.
00:10:00
Empowering Mid-Career Professionals with Coaching and Consulting Opportunities.
00:10:00
Exploring the journey of breaking into the electric vehicle market and establishing Asia's largest lithium-ion battery factory | Somphote Ahunai, CEO, Energy Absolute PCL.
00:10:00
Joachim Nielsen Discusses Proximar Seafood’s Strategic Move to Japan | Joachim Nielsen , CEO, Proximar Seafood AS.
00:10:00
Mastering Remote Work: Microsoft Technologies Webinar Recap | Russell Baskerville , CEO of Empired Ltd
00:10:00
Bittium 8.8.19 Q2 | Hannu Huttunen, CEO, Bittium OyjBITTI:HEX